Mandate

Vinge advises FSN Capital in connection with the acquisition of Seriline

Vinge advises FSN Capital in connection with the acquisition of a majority stake in Seriline AB from its current shareholders, who will retain a sizable stake in the company.

Serline was founded in 1990 and is a provider of Identity and Access Management (IAM) solutions. Seriline offers proprietary software, online solutions, hardware and services that simplify the flow to creating user-friendly processes for confidentiality and integrity management of identities. Seriline has 29 FTEs and had SEK 84m in sales in 2021. The company is expected to be the initial platform in FSN’s buy-and-build strategy to create a Nordic cybersecurity leader within IAM.

Established in 1999, FSN Capital Partners is a leading Northern European private equity firm and investment advisor to the FSN Capital Funds, with €4 billion under management. FSN Capital Funds make control investments in growth-oriented Northern European companies, to support further growth and to transform companies into more sustainable, competitive, international, and profitable entities. 

Vinge’s team mainly consisted of Johan Winnerblad, Maria Dahlin Kolvik, Eléonore Friberg and Ebba Nyberg (M&A), Mathilda Persson and Karolina Fuhrman (IT/GDPR), Martin Boström (Commercial agreements), Felix Möller (Bank and Finance), Gustav Lindgren (Arbetsrätt), Sofia Bergenstråhle och Axel Lennartsson (IP), Tove Lövgren Frisk (Compliance), Ellinor Gyllenhammar and Elin Kollin (VDR).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025